Luma Vision Ltd.
Clinical trials sponsored by Luma Vision Ltd., explained in plain language.
-
New 3D heart imaging could sharpen ablation precision
Disease control Not yet recruitingThis study tests a new imaging and guidance system called VERAFEYE that creates a 3D model of the heart to help doctors navigate during catheter ablation for atrial fibrillation. About 50 adults with paroxysmal or persistent atrial fibrillation will have their standard ablation p…
Phase: NA • Sponsor: LUMA Vision Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New 3D Heart-Mapping tool could sharpen AFib ablation
Disease control Not yet recruitingThis study tests a new device called the VERAFEYE System, which creates a 3D model of the heart to guide doctors during catheter ablation for paroxysmal atrial fibrillation (a type of irregular heartbeat). About 100 adults who are already scheduled for ablation will have the proc…
Sponsor: LUMA Vision Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New 3D Heart-Mapping device tested in 50-Patient registry
Knowledge-focused Not yet recruitingThis study will collect real-world information on the VERAFEYE system, a device that creates 3D images of the heart during procedures to treat atrial fibrillation (an irregular heartbeat) and to close the left atrial appendage (a small pouch in the heart). About 50 adults will ta…
Sponsor: LUMA Vision Ltd. • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC